Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

(33%)

Other 45% 13% 20%

(11%) 19% (6%)

Nine Months Ended

September 30,

2007

United

States Europe Total

Sales:

PROVIGIL $593,394 $39,171 $632,565

GABITRIL 39,814 6,268 46,082

CNS 633,208 45,439 678,647

ACTIQ 157,097 28,638 185,735

Generic OTFC 97,562 - 97,562

FENTORA 101,224 - 101,224

Pain 355,883 28,638 384,521

Other 53,867 170,767 224,634

$1,042,958 $244,844 $1,287,802

2006

United

States Europe Total

Sales:

PROVIGIL $494,047 $29,219 $523,266

GABITRIL 41,291 3,510 44,801

CNS 535,338 32,729 568,067

ACTIQ 452,175 19,213 471,388

Generic OTFC - - -

FENTORA - - -

Pain 452,175 19,213 471,388

Other 41,661 152,436 194,097

$1,029,174 $204,378 $1,233,552


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... Dec. 5 Genomic Health,...ompany will present results from,four studies at ...m, taking,place December 10-14, 2008, at the Henr...ies analyze Oncotype DX(R), the company,s multi-ge...to predict the likelihood of chemotherapy,benefit...
(Date:12/5/2008)...nd JERSEY CITY, New Jersey, December 5,/PRNewswir...ROSG ), an,innovative molecular diagnostic compan...day its consolidated financial results for the qua...ghts. , The company recorded revenues for t...ues were recorded from the date of acquisition of ...
(Date:12/4/2008)... Medivation, Inc.,(Nasd..., president and chief,executive officer, will be ...l,Markets 2008 Healthcare Conference on Thursday,...attle Against Cancer" from 8:00-8:55 a.m. Eastern ..." from 12:00-12:55 p.m. Eastern, Time, ,...
(Date:12/4/2008)...witzerland, Dec. 4 Octapharma,Cha...is D. Curtin has been,selected to lead Octapharma...,had been Octapharma,s U.S. legal counsel since 20...eutics, Inc. , The largest private plasma p... acquired Life Therapeutics, the Atlanta company t...
Breaking Biology Technology:Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 2Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2
...e big enough that no one is likely to see everythi...es where they,ll be during the marathon event that...this April 9 through 12. Here,s a sampling of thei...e applied to present as part of the Business Forum...ting and opportunities for companies to meet with ...
...1,000 scholarships and a top prize of $7,500 in se... in a business-plan competition sponsored by BizF...he Young Entrepreneur Foundation . , ,The contest...from U.S. college and high-school students until M..., , Young Entrepreneur Foundation: Contest guidel...
...s Bio Corporation says its scientists have develo...ly. , ,Antibodies, naturally part of the immune sy...iseases and for diagnostics or research. Mirus, ne...oTechniques, involves intravenously injecting DNA ...ibodies that are harvested and used. , ,According ...
...nt Lawrence H. Summers created a firestorm last ye...ion in math and science fields might be the result... women. While that comment may be only part of the..., it focused the spotlight on the need for more di..., diversity in top IT positions has a way to go, b...
Other Biology Technology:Where will you be at BIO? 2Diversity still an elusive goal in IT, other tech fields 2Diversity still an elusive goal in IT, other tech fields 3
(Date:12/4/2008)...ech Wake Forest University,s School of Biomedical...chanics has received the Army Modeling and Simulat...Chief of Staff of the Army and Director of the Arm...mately help save eyesight and reduce morbidity and... center was selected from 57 applicants from aroun...
(Date:12/4/2008)... looking for bonefish from Miami down to the Marqu...m, and that is down slightly from the average of p...ion among those who are counting, researchers spec... of Marine and Atmospheric Science held the sixth ...n with the conservation group Bonefish & Tarpon Un...
(Date:12/4/2008)... carry weight in the thighs and backside have been...re and heart disease than apple-shaped people who ...trition researchers at Washington University Schoo...arisons don,t completely explain risk. , In two ...e the real key to insulin resistance, cholesterol ...
(Date:12/4/2008)...ated with higher levels of omega-3 fatty acids in ...ing of the European study IMMIDIET that will be pu...nal of Clinical Nutriti on, an official publicatio...eady available on line ( www.ajcn.org ). The stud...lic drinks. This effect could be ascribed to compo...
Breaking Biology News(10 mins):New dummy design and development wins US Department of Defense award 2Bonefish census reveals population holding steady 2Apple or pear shape is not main culprit to heart woes -- it's liver fat 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 1PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 2PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 3PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 4PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 5PPD Reports Fourth Quarter and Year End 2007 Financial Results 11214 6Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 1Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13 2008 11209 2Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference 3088 1New Report Offers Comprehensive Look at Mental Health in Minnesota 11205 1New Report Offers Comprehensive Look at Mental Health in Minnesota 11205 2
...d that our brains fend off distractions. If we are...al influences. If we are tired, we can no longer d...the brain selects incoming information to remember... and neutral information may enter. In the event o... , Test , Psychologists carry out a lot of...
...ks a form of blood cancer in mice by engineering a...rtening the ends of chromosomes, called telomeres.... the cell commits suicide as a means of protecting...Nathans chair of molecular biology and genetics at...onth at Cancer Cell, uncovers an alternate respons...
...agen have demonstrated that the spinal cord use ne...n. The discovery is featured in the current issue ...ising results consists of Professor Jørn Hounsgaar... Copenhagen, and Assistant Professor and PhD Aidas...p has shown that spinal neurons, during network ac...
...f millions of hours of work productivity this spri...ver symptoms, including sneezing, watery eyes and ...n hour of work per week during peak hay fever seas...seem small, consider that 20 to 50 million America...ay fever, or allergic rhinitis, said Sheryl Szeinb...
Other Biology News:Brain fends off distractions 2Short chromosomes put cancer cells in forced rest 2Hay fever can send work productivity down the drain 2Hay fever can send work productivity down the drain 3
Zymoclean Gel DNA Recovery Kit from Zymo Research
Collected from 8-12 week-old New Zealand or Californian rabbits.,Supplied in lyophilized form.
DeadEnd Fluorometric TUNEL System from Promega
Agarose overlays are commonly used in baculovirus plaque assays. Many commercial "DNA grade" agaroses either contain contaminants that are toxic to insect cells or lack the physical characteristics r
Biology Products: